ARE Stock Recent News

ARE's Q2 earnings may dip as lower occupancy and lease-up risks weigh on revenues and FFO per share.

Alexandria Real Estate Equities, Inc. has massive potential to retake $100 quickly as fundamentals improve. Premier life science property locations, absurd rent collection, and good EBITDA margins, but occupancy running below what we would like. Robust ARE shareholder returns buoyed by a respectable balance sheet, but a we need to see updates on leverage.

PASADENA, Calif. , July 17, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, today announced it has been honored with the 2025 International TOBY (The Outstanding Building of the Year) Award in the Life Science category for 8 Davis Drive on the Alexandria Center® for Advanced Technologies Megacampus in Research Triangle.

Green bond issuance by US equity real estate investment trusts subsided in the first half of 2025, according to an S&P Global Market Intelligence analysis. Datacenter REIT Equinix was the sole US REIT to issue green bonds in the first half, raising roughly $1.67 billion through two euro-denominated offerings. Since 2018, 25 US REITs have issued green bonds, totaling $42.67 billion in proceeds.

ARE's securing of a long-term lease from a longtime multi-national pharmaceutical tenant highlights healthy demand for its San Diego Megacampus.

We are facing very high risks. Now is not the time to speculate with risky REITs. I present two REITs that I sold recently.

PASADENA, Calif. , July 14, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, today announced that it has executed a 16-year lease with a longtime multinational pharmaceutical tenant for a 466,598 RSF build-to-suit research hub on the Campus Point by Alexandria Megacampus in the University Town Center submarket of San Diego.

U.S. equity markets retreated from record highs this week after the White House reignited its tariff offensive with a wave of aggressive levies and additional punitive threats. While inflation data has indicated that the 10% tariffs were efficiently absorbed, the pivot back towards Liberation Day tariff levels raises concern that recent deflationary offsets may be overwhelmed. After closing at record highs for two straight weeks, the S&P 500 retreated by 0.3% this past week, trading in a relatively tight trading range as investors geared up for earnings season.

We prefer to buy and hold stocks with a significant margin of safety. Today, we're highlighting a global tech and e-commerce juggernaut, the leading life sciences REIT, and a major managed healthcare and insurance company. The stocks are priced 20% to 38% below our fair value estimates.

Alexandria Real Estate Equities is a best-in-class life sciences REIT trading at a deep discount, with fundamentals intact despite sector headwinds. The current nearly 7% dividend yield and a P/FFO at half its historical average create a compelling value opportunity for patient, long-term investors. Early signs of sector recovery—rising VC funding, employment, and leasing—suggest a bottoming and potential re-rating, especially if interest rates decline in 2026.